Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
14 December, 2007The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Fluorescent secondary antibodies and streptavidin conjugates
07 November, 2007NorthernLights (from R&D Systems) fluorescent secondary antibodies and streptavidin conjugates are bright and resistant to photobleaching.
FK1 and FK2 Horseradish Peroxidase Conjugates
06 July, 2007In order to investigate the status and extent of protein ubiquitinylation, it is necessary to have available a range of antibodies capable of differentiating firstly between free ubiquitin and ubiquitin-protein conjugates and, secondly, between those that are monoubiquitinylated and those that are polyubiquitinylated.
Monash University home to largest monoclonal antibody production facility in the Southern Hemisphere
05 July, 2007Monash University has joined forces with international life sciences supply company Tecan to develop a new state-of-the-art monoclonal antibody production system at the University's Clayton campus.
Protease Inhibitor Library
09 May, 2007The Screen-Wellâ„¢ Protease Inhibitor Library from BIOMOL International includes 53 known protease inhibitors on a single 96-well plate.
Sourcing stem cells
19 May, 2005Australia's medical research capability has been strengthened with the opening of a stem cell research precinct at the Monash University.
